MORE►
CPRIT
Gradalis CEO Steven Weinstein [Photo: Gradalis]
Biotech Co. Gradalis Names Former Novartis Exec as Its New CEO
by Sandra Engelland | Jan 14, 2026
With more than two decades of experience in life sciences leadership, venture capital, and company building, Steven Weinstein brings a track record of guiding innovative healthcare organizations from early-stage development through commercialization, Carrollton-based Gradalis said.
by Dallas Innovates | Staff Report |
Dec 5, 2025
The Cancer Prevention & Research Institute of Texas offers funding opportunities for promising cancer research, product development, and prevention programs. The state-funded initiative stands as the second-largest public backer of cancer research in the U.S. after the National Cancer Institute.
MORE►
by Glenn Hunter |
Sep 24, 2025
At Dallas’ iC3 Summit, leaders from Texas and across the U.S. pointed to AI, new state initiatives like Proposition 14, and potential federal reforms as keys to speeding innovation and keeping America competitive in life sciences.
MORE►
by Lance Murray |
Feb 27, 2024
Included in the 12 Dallas-area funding awards is a $4 million Rising Star grant to bring Stefan Gloeggler, Ph.D., to UT Southwestern Medical Center from the Max Planck Institute of Multidisciplinary Sciences in Göttingen, Germany.
MORE►
UT Southwestern Harold C. Simmons Comprehensive Cancer Center [Photo: UTSW]
Simmons Cancer Center Investigators Get Nearly $15M in CPRIT funding
by Lance Murray | Mar 13, 2023
“Our researchers continue to push the envelope on developing a better understanding of cancer and new ways to help cancer patients in Texas and beyond,” said Center Director Carlos L. Arteaga, M.D.
MORE►
by Dallas Innovates | Staff Report |
Feb 17, 2023
The Cancer Prevention and Research Institute of Texas approved over $90 million in new cancer research and prevention grants at its quarterly meeting near the Texas Capitol on Wednesday—and $20.6 million of that money is coming to North Texas to advance everything from breast cancer and lung cancer screening to "deep learning models" to facilitate T-cell receptor therapies.
MORE►
by Kevin Cummings |
Sep 6, 2022
The Cancer Prevention & Research Institute of Texas has provided more than $3.1 billion in funding toward the development of cancer-fighting therapeutics, devices, diagnostics, and tools since 2010. It's now issued a call for startups and early-stage companies to apply for product development research grants for the 2023 fiscal year.
“CPRIT’s mission is to invest in the research prowess of Texas institutions while expediting breakthroughs in cancer cures and prevention,” CEO Wayne Roberts said last May.
MORE►
by David Seeley |
Jun 30, 2022
At the 2022 BIO International Conference in San Diego, representatives from North Texas met "the greatest minds in biotechnology"—and discovered some of them are interested in relocating their companies to DFW.
"We connected with them to explore opportunities and increase investments in the Dallas region,” said a VP with the Dallas Regional Chamber.
"We connected with them to explore opportunities and increase investments in the Dallas region,” said a VP with the Dallas Regional Chamber.
MORE►
OncoNano's technology visualizes a tongue carcinoma in real time during a surgery in a Phase 1 clinical trial. [Image: OncoNano]
Southlake BioTech Startup Gets $10M Grant from CPRIT for Technology That ‘Lights Up’ Cancer
by Quincy Preston | Aug 20, 2020
OncoNano Medicine, a spinout of University of Texas Southwestern, uses pH as a biomarker to detect metastatic cancer. Its technology, which visualizes a tumor, could be a gamechanger.
MORE►
by Lance Murray |
Feb 26, 2020
Using innovative new technologies and targeted therapies, the Dallas biotech startup aims to help patients with cancer, give them hope, and prolong their lives.
MORE►
by Lance Murray |
Aug 27, 2019
Southlake-based biotech OncoNano received the largest grant in DFW with $15.4 million from the state agency that funds cancer research in Texas.
MORE►
by Lance Murray |
May 31, 2019
You’ll also find out about how a UT Dallas professor is trying to speed up transistors for chipmakers, and about how Caris Life Sciences’ new collaboration is developing a cancer diagnostic test in this roundup of research and development activity in North Texas.
MORE►
